Sio Capital Management, LLC Xencor Inc Transaction History

Sio Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$21.18 - $33.78 $2.33 Million - $3.72 Million	-109,981 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$19.29 - $24.83 $1.48 Million - $1.91 Million	76,881 Added 232.27%	109,981 $2.41 Million
Q3 2017 Nov 14, 2017	BUY	$19.61 - $23.35 $649,091 - $772,885	33,100	33,100 $759,000

204

63.1M

3.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.2B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.